Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have a confirmed diagnosis of a neurological condition, such as traumatic brain injury, cerebral palsy, brain injury caused by lack of oxygen, stroke, or another disorder affecting the brain or nervous system.
- People who have already received, or are planned to receive, a nose-delivered therapy using a specific type of cell product (MuSE cell-derived exosomes, MuSE stem cells, or a combination of both) given through a particular delivery device called the Kurve Therapeutics ViaNase system, as part of their regular medical care outside of this study.
- People for whom a specific blood test result (measuring a protein called TNF-α, which is involved in inflammation) is already available or can be taken before treatment begins.
- People who are able to give their own consent to participate, or who have a legal representative who can do so on their behalf.
- People who are willing to attend follow-up appointments, which include blood tests and assessments of health outcomes.
- People whose overall health condition has been stable for at least two weeks before the initial study assessment.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have an active infection affecting the whole body at the time of enrolling in the trial.
- People who have used certain medications that broadly suppress the immune system or target inflammation (which could affect the TNF-α blood test result) within the 30 days before the initial blood test.
- People for whom the required blood tests (before or during the study) cannot be obtained.
- People whose treatment records are incomplete, meaning the type, amount, or method of treatment given is not fully documented.
- People with any other medical condition that the trial doctor believes would make it difficult to interpret the study results (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Serum Tumor Necrosis Factor Alpha (TNF-α) From Baseline to 1 Month; Incidence of Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.